Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Needle Could Reduce Medical Complications

By HospiMedica International staff writers
Posted on 21 Apr 2009
A new needle, based on concepts borrowed from the oil industry, aims to prevent hypodermic needles from penetrating too far under their skin by keeping them "on target."

Researchers from the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) developed the new needle, which involves a hollow S-shaped needle containing a filament that acts as a guide wire. More...
When a physician pushes the device against a tissue, force is applied to the filament, not the needle itself, due to a special clutch mechanism. When the filament, which moves through the tip of the needle, encounters resistance from a firm tissue, it begins to buckle within the S-shaped tube.

Due to the combined buckling and interactions with the walls of the tube, the filament locks into place, and the needle and wire advance as a single unit. The needle and wire then proceed through the firm tissue. However, once they reach the target cavity (for example, a blood vessel) there is no more resistance on the wire, and it quickly advances forward while the needle remains stationary. Because the needle is no longer moving, it cannot proceed past the cavity into the wrong tissue. A similar locking phenomenon has long been observed in drill strings inside drill shafts used by the oil-drilling industry. The study describing the new technology was published in the April 7, 2009, issue of the Proceedings of the [U.S.] National Academy of Sciences (PNAS).

Insertion of trocars, needles, and catheters into unintended tissues or tissue compartments results in hundreds of thousands of complications annually. Current methods for blood vessel cannulation or epidural, chest tube, and initial trocar placement often involve the blind pass of a needle through several layers of tissue and generally rely on anatomic landmarks and a high degree of clinical skill.

Related Links:
Massachusetts Institute of Technology



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.